ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's launches medication to treat chronic constipation
Dr Reddy's Laboratories has launched BixiBat, a new drug for chronic constipation in India. It is the first company to receive approval from the CDSCO for Elobixibat. The drug works by increasing bile acid concentration in the colon, promoting bowel moveme
Announcement as on 28 October 2024

Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor
Announcement as on 02 October 2024

Dr Reddy's ties up with Gilead to manufacture, commercialise HIV drug
Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of the HIV drug Lenacapavir in India and 120 other countries. The company has entered into a royalty-free non-exclusive voluntary licens
Announcement as on 02 October 2024

Dr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drug
Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agreement includes developing Lenacapavir for both treatment and potential prevention of HIV. This collaboration aims
Announcement as on 02 October 2024

Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category. Dr Reddy's Laborato
Announcement as on 30 September 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.3
  • 12Day Average: 14.53
  • 20Day Average: 14.04
  • 50Day Average: 13.66
  • 100Day Average: 13.76
  • 150Day Average: 13.77
  • 200Day Average: 13.84

RDY Indicators & signals

Indicator MACD (12,26,9)

14.3, 14.05, 0.27
Indicator MACD is in positive zone

Indicator ADX (14)

3.45, 34.15, 36.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.15 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 0.81 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.35 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.64 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.05 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 1 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.57 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.09 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.36 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.92 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.22 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.95 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top